Buyback in Pharma: Expiry Returns & Compensation
Pharma expiry returns and compensation in India's CFA/stockist model — saleable vs breakage returns, return windows, valuation and credit-note settlement.
Buyback in pharma is the return of expired or near-expiry medicine from stockists and retailers up the chain, with the manufacturer compensating the value — usually by credit note. It runs within the CFA/stockist model and follows defined return windows and valuation rules, with regulated handling for expired drugs.
The stockist return chain
Pharma returns flow back up through retailers and stockists to the C&F and manufacturer. Because medicine has hard expiry dates and strict handling rules, expiry returns are a structural part of pharma economics, not an exception. This is the pharma view of the buyback hub, paired with pharma chargebacks.
Verify at publish: confirm current expired-drug handling/destruction requirements and return-window norms before stating specifics; this is not regulatory advice.
Saleable vs breakage/expiry
| Type | Condition | Handling |
|---|---|---|
| Saleable return | Good condition | Often resaleable; valued accordingly |
| Breakage / expiry | Damaged or expired | Not resaleable; regulated destruction |
The two are valued and processed differently — conflating them is a common source of error.
Return windows and valuation
Windows and valuation define the cost. Return windows specify how close to or past expiry stock can be returned; valuation rules set the compensation. Clear rules keep the program managed and the claim verifiable. The mechanics mirror the buyback process; the stockist-claim view is distributor claims management (pharma uses "stockist").
Regulated handling
Expired medicines carry regulatory handling and destruction obligations that ordinary FMCG stock does not. Any process or software must keep an auditable record of what was returned, valued, settled and destroyed. Treat the specific regulatory requirements as something to verify with a qualified professional, not to assert from a template.
GST note: This article is general information, not tax, legal or regulatory advice. Credit notes on returns and other GST positions — including CBIC Circular No. 251/08/2025-GST and the Finance Act 2026 amendments to Section 34 of the CGST Act, assented 30 March 2026 but not yet notified into force as of publication — must be re-verified at publish time with a qualified professional.
Frequently asked questions
What is buyback in pharma?
Pharma buyback is the return of expired or near-expiry medicine from stockists and retailers up the chain, with the manufacturer compensating the value, usually by credit note. It operates within the CFA/stockist model and follows defined return windows and valuation rules.
What is the difference between saleable and breakage/expiry returns?
Saleable returns are stock returned in good condition, often resaleable. Breakage and expiry returns are damaged or expired stock that cannot be resold and must be handled and destroyed per regulation. They are valued and processed differently.
How are pharma expiry returns settled?
After eligibility and valuation are confirmed and the return logged, the value is settled to the stockist, usually by GST credit note. Expired-drug handling must follow applicable regulatory requirements, which should be verified with a qualified professional.
See ClaimDS on your own claims data
A 30-minute walkthrough tailored to how your channel actually settles claims.
Related posts
What Is Claims Management Software? A Practical Guide
Claims management software, explained: what it is, the claim lifecycle, the Indian claim types it settles, GST credit notes, and how to choose one.
How to Submit Rebate Claims Fast and Accurately with ClaimDS
A step-by-step guide to submitting rebate and scheme claims fast and accurately: the documents, the 5 steps, GST credit notes, and how to cut rejections.
Distributor Claim Settlement Software: A Buyer's Guide for Indian Mid-Market
What distributor claim settlement is, why spreadsheets fail at scale, what to look for in software, and how ClaimDS helps Indian mid-market finance teams.